|
|
|
|
| LEADER |
03032nam a2200325 u 4500 |
| 001 |
EB000943706 |
| 003 |
EBX01000000000000000737296 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 100 |
1 |
|
|a Dolor, Rowena J.
|
| 245 |
0 |
0 |
|a Treatment strategies for women with coronary artery disease
|h Elektronische Ressource
|b future research needs : identification of future research needs from Comparative effectiveness review no. 66
|c prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Duke Evidence-based Practice Center ; investigators, Rowena J. Dolor, Manesh R. Patel, Chiara Melloni, Ranee Chatterjee, Brooke L. Heidenfelder, Michael D. Musty, Megan Chobot, R. Julian Irvine, Gillian D. Sanders
|
| 260 |
|
|
|a Rockville, MD
|b Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|c [2013], 2013
|
| 300 |
|
|
|a 1 PDF file (various pagings)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Comparative Effectiveness Research
|
| 653 |
|
|
|a Women's Health
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Coronary Artery Disease / therapy
|
| 710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
| 710 |
2 |
|
|a Duke University Evidence-based Practice Center
|
| 710 |
2 |
|
|a Effective Health Care Program (U.S.)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Future research needs papers
|
| 500 |
|
|
|a Title from PDF title page. - Based on: Treatment strategies for women with coronary artery disease / prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Duke Evidence-based Practice Center ; investigators, Rowena J. Dolor ... [et al.]. 2012
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK148780
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 700
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Cardiovascular disease remains the leading cause of death among women in the United States. More than 500,000 women die of cardiovascular disease each year, exceeding the number of deaths in men and the next seven causes of death in women combined. This translates into approximately one death every minute. This report focuses on women because of the differences in clinical presentation and coronary anatomy, which affect the treatment options for coronary artery disease (CAD). Currently available guidelines and systematic reviews provide specific treatment recommendations for women only among a subset of treatment options, and overall assume that treatment options are equally effective for both sexes when gender data are not available. However, women have a worse prognosis than men for manifestations of CAD such as acute myocardial infarction (MI), and some data suggest that women and men do not respond equally to the same treatments. Further, women are more likely than men to experience bleeding complications
|